Scopolamine Transdermal System shortage
To Be Discontinued 1 presentations · 1 manufacturers · first FDA posting 2025-11-03 · last update 2025-11-03
Manufacturers: Padagis US LLC
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Scopolamine, Transdermal System, 1 mg (NDC 45802-580-46) | Padagis US LLC | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 11/03/2025 Updated 11/03/2025 Discontinued 11/03/2025 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)